Of note, withinthe pMDC population, cells with high CD33 expression levels (population B inFigure 2(a)) were significantly decreased in the cancer patients beforetreatment, as compared to the healthy donors (P = .02, Figure 2(c)). The gene discussed is CD33; the disease is cancer.